Thermo Fisher Acquires Open Biosystems for RNAi Technology
Luke Timmerman7/1/08
Thermo Fisher Scientific (NYSE: TMO) said today it has acquired Open Biosystems, a maker of RNA interference products for research and development of new drugs. Thermo, based in Waltham, MA, didn’t disclose the purchase price, although it did say Huntsville, AL-based Open Biosystems had $14 million in revenues in 2007. Open Biosystems specializes in short-hairpin RNAs, and viral vector systems for delivering short-hairpin RNA molecules into cells, Thermo said.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
